CAJ | 학술논문

采用流体化床Fenton装置深度处理合成制药废水,通过正交试验确定了处理合成制药废水的最佳条件是HRT为20min,初始pH值为4.0,H2O2/CODcr（质量比）为4.0,H2O2/Fe2＋（摩尔比）为15,且在最佳条件下出水CODcr稳定在80mg/L以下,可以达到《污水综合排放标准》（GB8979-1996）一级标准。同时将其与标准Fenton氧化法进行对比试验,结果显示流体化床FentonCODcr去除率可提高13%以上,污泥产生量可降低70%,运行成本可减低28%,稳定运行成本可以控制在3.0元/吨废水以内。
채용류체화상Fenton장치심도처리합성제약폐수,통과정교시험학정료처리합성제약폐수적최가조건시HRT위20min,초시pH치위4.0,H2O2/CODcr（질량비）위4.0,H2O2/Fe2＋（마이비）위15,차재최가조건하출수CODcr은정재80mg/L이하,가이체도《오수종합배방표준》（GB8979-1996）일급표준。동시장기여표준Fenton양화법진행대비시험,결과현시류체화상FentonCODcr거제솔가제고13%이상,오니산생량가강저70%,운행성본가감저28%,은정운행성본가이공제재3.0원/둔폐수이내。
The fluidized-bed Fenton reactor was employed for advanced treatment of synthesis pharmaceutical wastewater.Through orthogonal tests,the best reaction conditions for synthesis pharmaceutical wastewater treatment were determined as 20 min of HRT,4.0 of initial pH value,4.0 of H2O2/CODcr mass ratio and 15 of H2O2/Fe2＋ Moore ratio.Under those optimum conditions,CODcr concentration of the effluent was detected stably below 80 mg/L,which complies with the Class A of Integrated Wastewater Discharge Standard（GB8978-1996）.Comparing to the standard Fenton oxidation,the application of fluidized-bed Fenton reactor resulted in an improvement of over 13% on CODcr removal efficiency,as well as a reduction of 70% on sludge yield.Accordingly,the operating costs can be reduced by 28%,which could be controlled within 3.0 yuan/tons wastewater in stable conditions.